Balance sheet of Fredun Pharma is strong.
But short term working capital might become an issue for this company.

Yes, The net debt of Fredun Pharma is increasing.
Latest net debt of Fredun Pharma is ₹162 Crs as of Mar-25.
This is greater than Mar-24 when it was ₹103 Crs.

Yes, profit is increasing.
The profit of Fredun Pharma is ₹23.44 Crs for TTM, ₹15.62 Crs for Mar 2024 and ₹10.81 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Fredun Pharma latest dividend payout ratio is 2.11% and 3yr average dividend payout ratio is 3.31%

Companies resources are allocated to majorly unproductive assets like Inventory, Accounts Receivable